Granulocyte-macrophage colony-stimulating factor precursor
Brand names,
Granulocyte-macrophage colony-stimulating factor precursor
Analogs
Granulocyte-macrophage colony-stimulating factor precursor
Brand Names Mixture
Granulocyte-macrophage colony-stimulating factor precursor
Chemical_Formula
C639H1006N168O196S8
Granulocyte-macrophage colony-stimulating factor precursor
RX_link
http://www.rxlist.com/cgi/generic/sargramostim.htm
Granulocyte-macrophage colony-stimulating factor precursor
fda sheet
Granulocyte-macrophage colony-stimulating factor precursor
msds (material safety sheet)
Granulocyte-macrophage colony-stimulating factor precursor
Synthesis Reference
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
Molecular Weight
14434.5
Granulocyte-macrophage colony-stimulating factor precursor
Melting Point
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
H2O Solubility
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
State
Liquid
Granulocyte-macrophage colony-stimulating factor precursor
LogP
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
Dosage Forms
Solution (IV Infusion); Solution (Subcutaneous Injection)
Granulocyte-macrophage colony-stimulating factor precursor
Indication
For the treatment of cancer and bone marrow transplant
Granulocyte-macrophage colony-stimulating factor precursor
Pharmacology
Sargramostim is used in the treatment of bone marrow transplant recipients or those exposed to chemotherapy an recovering from acut myelogenous leukemia, Leukine or GM-CSF is a hematopoietic growth factor which stimulates the survival, clonal expansion (proliferation) and differentiation of hematopoietic progenitor cells. GM-CSF is also capable of activating mature granulocytes and macrophages. After a bone marrow transplant or chemotherapy, patients have a reduced capacity to produce red and white blood cells. Supplementing them with external sources of GM-CSF helps bring the level of neutrophils back to normal so that they can better fight infections.
Granulocyte-macrophage colony-stimulating factor precursor
Absorption
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
side effects and Toxicity
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
Patient Information
No information avaliable
Granulocyte-macrophage colony-stimulating factor precursor
Organisms Affected
No information avaliable